Petalouda Therapeutics

Private

—Healthcare & Life Scienceshttps://www.petaloudatherapeutics.com/

Company Overview

Petalouda Therapeutics is a biotechnology company that designs and develops RNA therapeutics to treat refractory chronic pain disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

RNA therapeuticsdrug discoverychronic painbiotech startuppre-clinical researchcontract research organizationCRObiotechdrug developmentpain managementrefractory painbiotech pipelinetherapeutic candidateearly-stage biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Petalouda Therapeutics Comparables

Compare Petalouda Therapeutics with similar companies based on industry and business-model similarity.

Petalouda Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Dolinnov	89%
Navega Therapeutics	79%
Adolore Biotherapeutics, Inc.	76%

View all Comparables

Petalouda Therapeutics Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Petalouda Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Petalouda Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Petalouda Therapeutics's valuation, stock price, and market status.

Firmographic Details

Headquarters—

Year FoundedN/A

Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?